NORDIC BIOTECH ADVISORS ApS: Financial statements 2021
CVR: 26123925
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NORDIC BIOTECH ADVISORS ApS (CVR 26123925) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,700,141 and a net result of DKK 657,338 compared with DKK -301,432 the year before. That is an increase of 35.5% compared with the year before. Equity in the 2021 report amounted to DKK 2,459,120. The solvency ratio was 75.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,700,141
- Profit/Loss
- DKK 657,338
- Equity
- DKK 2,459,120
- Total Assets
- DKK 3,241,350
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 3.7M | 657K | 2.5M | 2 |
| 2020 | - | 2.7M | -301K | 1.8M | 2 |
| 2019 | - | 3.3M | 81K | 2.1M | 2 |
| 2018 | - | 3.4M | -119K | 2M | 1 |
| 2017 | - | 3.1M | 86K | 2.1M | - |
Official annual report
Find more companies like NORDIC BIOTECH ADVISORS ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2020. Gross profit came to DKK 2,730,002, and the net result was DKK -301,432.
About NORDIC BIOTECH ADVISORS ApS
NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.
